Novel modes of glucocorticoid replacement therapy in adrenal insufficiency
- Prosjektnummer
- 911806
- Ansvarlig person
- Kristian Løvås
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Metabolic and Endocrine
- Forskningsaktivitet
- 5. Treatment Developement
Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure.
Eur J Endocrinol 2016 Jan;174(1):97-105. Epub 2015 okt 22
PMID: 26494876
Adrenal Insufficiency Therapy: How to Keep the Balance between Good Quality of Life and Low Risk for Long-Term Side Effects?
Front Horm Res 2016;46():196-210. Epub 2016 mai 23
PMID: 27212041
Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Clin Endocrinol (Oxf) 2015 Jul;83(1):28-35. Epub 2015 jan 12
PMID: 25400085
Optimal glucocorticoid replacement in adrenal insufficiency.
Best Pract Res Clin Endocrinol Metab 2015 Jan;29(1):3-15. Epub 2014 okt 7
PMID: 25617168
Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
J Clin Endocrinol Metab 2014 May;99(5):1665-74. Epub 2014 feb 11
PMID: 24517155
Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison’s disease
Journal of Clinical Endocrinology and Metabolism, akseptert 21.1.14
- Eystein Sverre Husebye Leder av forskningsgruppe
- Marianne Øksnes Prosjektdeltaker
- Katerina Simunkova Postdoktor
- Kristian Løvås Prosjektleder
- Nevena Jovanovic Prosjektdeltaker
- Paal Methlie Postdoktor
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest